2,640
Participants
Start Date
March 31, 2013
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
Flublok
A Biologics Licensing Application (BLA) for Flublok was approved by the FDA for influenza immunization of adults 18-49 years of age. Flublok is produced using recombinant technology under serum-free conditions.
Afluria
Afluria is approved for use in persons 5 years of age and older and is produced by inactivation and disruption of live influenza virus grown in embryonated chicken eggs.
Regional Clinical Research, Binghamton
Wake Research, Raleigh
Meridian Clinical Research, Savannah
Clinical Research of South Florida, Coral Gables
Rapid Medical Research, Inc., Cleveland
Heartland Research Associates, LLC, Wichita
Meridian Clinical Research, Omaha
Benchmark Research, Metairie
Research Across America, Dallas
Benchmark Research, Fort Worth
Benchmark Research, San Angelo
Clinical Research Center of Nevada, LLC, Las Vegas
Genova Clinical Research, Tucson
Maine Research Associates, LLC, Auburn
Protein Sciences Corporation
INDUSTRY